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Our previous work identified E3 ubiquitin ligases, termed
UBR1–UBR7, that contain the 70-residue UBR box, a motif
important for the targeting of N-end rule substrates. In this
pathway, specific N-terminal residues of substrates are recog-
nized as degradation signals by UBR box-containing E3s that
include UBR1, UBR2, UBR4, and UBR5. The other E3s of this
set, UBR3, UBR6, and UBR7, remained uncharacterized. Here
we describe the cloning and analyses of mouse UBR3. The sim-
ilarities of UBR3 to the UBR1 and UBR2 E3s of the N-end rule
pathway include the RING and UBR domains. We show that
HR6A andHR6B, the E2 enzymes that bind to UBR1 andUBR2,
also interact with UBR3. However, in contrast to UBR1 and
UBR2, UBR3 does not recognize N-end rule substrates.We also
constructedUBR3-lackingmouse strains. In the 129SvImJback-
ground,UBR3/mice died during embryogenesis, whereas the
C57BL/6 backgroundUBR3/mice exhibited neonatal lethal-
ity and suckling impairment that could be partially rescued by
litter size reduction. The adult UBR3/ mice had female-spe-
cific behavioral anosmia. Cells of the olfactory pathway were
found to express -galactosidase (LacZ) that marked the dele-
tion/disruption UBR3 allele. The UBR3-specific LacZ expres-
sion was also prominent in cells of the touch, vision, hearing,
and taste systems, suggesting a regulatory role of UBR3 in
sensory pathways, including olfaction. By analogy with func-
tions of the UBR domain in the N-end rule pathway, we pro-
pose that the UBR box of UBR3 may recognize small com-
pounds that modulate the targeting, by this E3, of its
currently unknown substrates.
A protein substrate of the ubiquitin (Ub)2-proteasome sys-
tem, which controls the levels of many intracellular proteins, is
conjugated to Ub through the action of E1, E2, and E3 enzymes
(1–4). The selectivity of ubiquitylation is mediated largely by
E3, which recognizes a substrate’s degradation signal (degron)
(5–8). The E3 Ub ligases are an exceptionally large family, with
more than 500 distinct E3s in a mammal (9, 10). The term “Ub
ligase” denotes either an E2–E3 holoenzyme or its E3 compo-
nent. A ubiquitylated protein bears a covalently linked poly-Ub
chain and is targeted for processive degradation by the 26 S
proteasome (11). Ub has other functions as well, including non-
proteolytic ones (12, 13). An essential determinant of one class
of degrons, called N-degrons, is a substrate’s destabilizing
N-terminal residue. The set of destabilizing residues in a given
cell type yields a rule, called theN-end rule, which relates the in
vivohalf-life of a protein to the identity of itsN-terminal residue
(Fig. 1A) (4, 14–19). In eukaryotes, the N-degron consists of
three determinants: a destabilizingN-terminal residue of a pro-
tein substrate, its internal Lys residue(s) (the site of formation
of a poly-Ub chain), and a conformationally flexible region(s) in
the vicinity of these determinants (5, 7, 15, 20, 21).
The N-end rule has a hierarchic structure in that some of the
destabilizing N-terminal residues (Arg, Lys, His, Phe, Leu, Trp,
Tyr, and Ile) are recognized directly by E3 Ub ligases of the
N-end rule pathway, called N-recognins, whereas the other
destabilizingN-terminal residues (Asn, Gln, Asp, Glu, and Cys)
must be modified in vivo, enzymatically or otherwise, for their
subsequent (indirect) recognition by these E3s (Fig. 1A) (18, 19,
22–25). The functions of the N-end rule pathway include its
roles in the control of signaling by nitric oxide and G protein-
coupled receptors (GPCRs), the regulation of peptide import,
the fidelity of chromosome segregation, the apoptosis, meiosis,
cardiovascular development, neurogenesis, and pancreatic
functions, and leaf senescence in plants (16, 18, 24–32).
The N-end rule pathway of the yeast Saccharomyces cerevi-
siae is mediated by a single N-recognin, the Ub ligase UBR1
(33), whereas at least four N-recognins, including UBR1, medi-
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ate this pathway in mammals (16, 17, 31, 34). Our recent study
(17) identified a family ofmammalian E3Ub ligases that share a
characteristic zinc finger-like70-residue domain termed the
UBR box. The mouse genome encodes at least seven UBR box-
containing proteins, termed UBR1–UBR7, which vary both in
size (from 50 to 570 kDa) and in containing or lacking other
E3-characteristic domains, such as HECT, RING, PHD, or
F-box (Fig. 1B) (17). UBR1 and UBR2 of this set, the highly
homologous (47% identical) 200-kDa E3s, are the known
N-recognins of the mouse N-end rule pathway (16, 34).
In the S. cerevisiae RING-type UBR1 Ub ligase and also (by
inference) in its mammalian homologs UBR1 and UBR2, the
UBR box and nearby regions mediate the recognition of N-de-
grons (i.e. the binding of N-recognin to a primary destabilizing
N-terminal residue (Arg, Lys, His, Phe, Leu, Trp, Tyr, or Ile) of
a polypeptide) (16, 33). S. cerevisiae UBR1 recognizes type-1
(basic) destabilizing N-terminal residues Arg, Lys, and His
through a binding site that resides at least in part in the UBR
box. UBR1 recognizes type-2 (bulky hydrophobic) N-terminal
residues Phe, Leu, Trp, Tyr, and Ile through a nearby but genet-
ically distinguishable domain that includes the UBR box and a
proximal downstream region (see Refs. 17, 33, and 35 and ref-
erences therein). S. cerevisiaeUBR1 contains yet another (third)
substrate-binding site. Its activity is allosterically controlled by
occupancy states of the other two (type-1 and type-2) binding
sites of UBR1. The third substrate-binding site targets the tran-
scriptional repressor CUP9, through an internal degron near
the C terminus of CUP9 (26, 33). Since mouse UBR1 and UBR2
are homologs of S. cerevisiae UBR1 (16, 36), one would expect
these mammalian Ub ligases to also contain analogous (third)
substrate-binding sites (Fig. 1A). Indeed, mouse UBR1 was
shown to target c-FOS, a component of the AP-1 transcription
factor, for ubiquitylation and subsequent degradation through
a conditional (regulated by phosphorylation) degron near theN
terminus of c-FOS (37). Several otherUBR box-containing pro-
teins, such as UBR4 (PUSHOVER/BIG) and UBR5 (EDD/
hHYD), are also, operationally, N-recognins whose substrate
specificities include the ability to recognize primary destabiliz-
ing N-terminal residues (Fig. 1A) (17).
We have previously characterized mammalian UBR1, UBR2,
UBR4, and UBR5 as Ub ligases of the N-end rule pathway that
recognize destabilizing N-terminal residues (16, 17, 34, 36). In
the present study, we cloned and characterized mouse UBR3, a
protein of unknown function that contains both the UBR box
and the RING domain. Our findings show that UBR1, UBR2,
and UBR3 are structurally related members of the RING-UBR
subfamily of UBR-box E3s that interact (and function
together) with the E2 enzymes HR6A and HR6B. We also
constructed and characterized mouse strains lacking UBR3
and describe several lines of evidence suggesting that one
function of UBR3 involves the regulation of sensory path-
ways, including olfaction.
EXPERIMENTAL PROCEDURES
Cloning of the UBR3 cDNA—A 412-bp cDNA fragment that
encompassed a 3-proximal region of the UBR3 ORF (see
“Results”) was used as a probe to screen a EXlox-based embry-
onic day 10 (E10)mouse embryo cDNA library (Novagen,Mad-
ison, WI), yielding a 2.5-kb UBR3 cDNA fragment. This frag-
ment was employed as a probe in a second screen, using a
gt10-based mouse cDNA library from MEL-C19 cells (Clon-
tech) and yielding in a 1-kb fragment. Two subsequent screen-
ings yielded 2-kb and 1.5-kb fragments. To isolate the 5 region
ofUBR3 cDNA, 5-rapid amplification of cDNA ends PCR was
performed with poly(A) RNA from mouse liver or skeletal
muscle. The resulting set of overlapping cDNA fragments were
joined to produce full-lengthUBR3 cDNAs encoding two splic-
ing-derived isoforms.
Construction of UBR3/Mouse Strains—The mouseUBR3
gene was isolated by screening a bacterial artificial chromo-
some (BAC) DNA library (Genome Systems, St. Louis, MO)
from 129SvJmouse embryonic stem (ES) cells by using aUBR3-
specific cDNAprobe (nucleotides 385–1,886). The exon/intron
organization of the first30 kb of UBR3 was determined using
exon-specific PCR primers to amplify genomicDNA fragments
flanked by exons as previously described (34). The targeting
vector was constructed using standard techniques, linearized
with KpnI, and electroporated into CJ7 ES cells, followed by
standard procedures for selection and identification of cor-
rectly targeted UBR3/ ES cell colonies by using PCR and
Southern hybridization (16, 22, 24, 34, 38). The resulting
UBR3/ ES cell clones (6 of 960 ES cell clones analyzed) were
further selected for apparently normal karyotypes. Four inde-
pendently producedUBR3/ ES cell clones were injected into
C57/BL6J blastocysts to generate chimericmice. In two of these
mice, the mutant (UBR3) allele was transmitted to the germ
line. Northern and Southern hybridizations and PCR-mediated
genotyping were carried out as described (34).
GST Pull-down Assays—Glutathione S-transferase (GST)
pull-down assays were carried out as described (16). N-termi-
nally FLAG-tagged mouse fUBR1, fUBR2, and fUBR3 and S.
cerevisiae fUBR1 (sc-fUBR1) were expressed in S. cerevisiae
SC295 (MATa, GAL4 GAL80 ura3-52, leu2-3,112 reg1-501
gal1 pep4-3) from the PADH1 promoter in a high copy vector.
X-SCC1-GST fusions (where X represents Met, Arg, or Leu)
were produced using the IMPACT (intein-mediated purifica-
tion with an affinity chitin-binding tag) system (New England
Biolabs, Ipswich, MA) as previously described (16). N-terminal
residues of the test proteins were verified by Edman sequencing
of purified X-SCC1-GST fusions. GST fusions to mouse HR6A
and HR6B (GST-HR6A and GST-HR6B) were expressed in
Escherichia coli BL21(DE3) and purified as described (16). The
purifiedX-SCC1-GST (2g) in 250l of the loading buffer (137
mMNaCl, 2.7mMKCl, 4.3mMNa2HPO4, 1.4mMKH2PO4, 10%
glycerol, and 1%TritonX-100, pH7.4)was incubatedwith 15l
of glutathione-Sepharose beads (Amersham Biosciences) for
1 h at 4 °C. The beads were washed once with the loading buffer
and twice with the binding buffer (10% glycerol, 0.1% Nonidet
P-40, 0.2 M KCl, 1 mM dithiothreitol, and 50 mM HEPES, pH
7.5). The diluted yeast extracts (250 l) containing E3s in bind-
ing buffer containing the protease inhibitor tablet (Roche
Applied Science)were added into thewashed beads. The bound
proteinswere eluted, fractionated by SDS-PAGE, and immuno-
blotted with anti-FLAG antibody. The 5% input lanes (see Fig.
2) refer to a directly loaded sample of the yeast extract that
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corresponded to 5% of the extract amount used in GST pull-
down assays.
X-Peptide Pull-down Assay—X-Peptides (X-Ile-Phe-Ser-
Thr-Asp-Thr-Gly-Pro-Gly-Gly-Cys, where X represents Arg,
Phe, Gly, Ser, Thr, Ala, Asp, or Met), where residues 2–9 were
derived from residues 2–9 of Sindbis virus polymerase nsP4,
were synthesized as described (17). S. cerevisiae extract express-
ing mouse fUBR1, fUBR2, or fUBR3 was diluted by the lysis
buffer (10% glycerol, 0.1% Nonidet P-40, 0.2 M KCl, 1 mM dithi-
othreitol, and 50 mM HEPES, pH 7.5) to 1.2 mg/ml of total
protein and thereafter incubated with or without an added
dipeptide for 15 min on ice to prevent proteolytic degradation
of peptide substrates. A sample (0.3 ml) was then transferred to
a new tube containing 5 l (packed volume) of a carrier-linked
12-mer peptide, followed by gentle mixing, through rotation of
the tube, for 1 h at 4 °C. The beads were pelleted by a brief
centrifugation and then washed three times, for 2 min each,
with the lysis buffer. The beads were then suspended in 20l of
SDS-PAGE loading buffer and heated at 95 °C for 5 min, fol-
lowed by a brief spin in amicrocentrifuge, SDS-8% PAGE of the
supernatant, and detection of fUBR1, fUBR2, or fUBR3 by
immunoblotting with anti-FLAGM2 antibody.
Antibody to Mouse UBR3—An affinity-purified polyclonal
rabbit antibody to mouse UBR3 was produced using standard
methods (34, 38, 39), using purified GST-UBR3-(182–598)
fusion as an antigen. This antibody was employed to detect
endogenous UBR3 through a combination of immunoprecipi-
tation and immunoblotting (see Fig. 3D and “Results”).
LacZ Staining, Immunohistochemistry, and Northern
Hybridization—LacZ staining (using 5-bromo-4-chloro-3-in-
dolyl--D-galactopyranoside) and Northern hybridization
(with a UBR3-specific 32P-labeled cDNA probe) were carried
out as described (24). LacZ-stained embryos were postfixed,
photographed, and sectioned after embedding in paraffin.
Alternatively, the tissues were frozen in OCT medium after
fixation, cryosectioned, and stained for LacZ on the slides. For
immunohistochemistry, specific tissues were isolated, fixed in
4% formaldehyde, treated with 70% ethanol, dehydrated, and
embedded in paraffin wax as described (16), followed by sec-
tioning and staining with hematoxylin/eosin or an antibody.
ForNorthern hybridization, amouse adult tissue blot (Seegene,
Seoul, Korea) containing total RNAs isolated from the brain,
heart, lung, liver, spleen, kidney, stomach, small intestine, skel-
etal muscle, thymus, testis, uterus of nonpregnant female, and
E17.5 placenta was hybridized with 32P-labeled cDNA frag-
ments of mouse UBR3 or human -actin. Northern analyses
were also done with total RNAs from UBR3/ brains and
hearts versus their wild-type counterparts.
Assays for Neurotransmitters, Amino Acids, and Neuro-
trophins—Individual brains for each UBR3 genotype (/,
/, and /) at the stages of E18 and postnatal day 1 (P1)
were collected (6–8 brains of each genotype) to measure neu-
rotransmitters and related compounds as described (40). The
levels of monoamines (noradrenaline, dopamine, and sero-
tonin) and their metabolites were determined using high per-
formance liquid chromatography (HPLC)with electrochemical
detection. Amino acids were measured using HPLC and fluo-
rescence spectroscopy (41). The levels of nerve growth factor
and brain-derived neurotrophic factor in the brains were deter-
mined by enzyme-linked immunoassay (42).
Odor-based Behavioral Tests—Odorant discrimination tests
were performed largely as described (43) with minor modifica-
tions.UBR3/mice (7–17 weeks old) with littermate controls
(/ and UBR3/) were individually housed in filter-topped
cages 2 days before the test. On the third day, the test mouse
was relocated to a designated area away from other mice and
was left there for 30 min to allow accommodation to the envi-
ronment. Pretraining sessions and odorant tests with mice are
described under “Results.” Odorant solutions (50 M) were
made freshly in deionized water (for isoamyl acetate and ethyl
vanillin) or mineral oil (for geraniol and citral). One experi-
menter performed the entire set of odorant tests without know-
ing the genotypes of mice being tested.
RESULTS
Cloning of Mouse cDNAs Encoding UBR3—Data base search
using UBR1 and UBR2 sequences as probes brought forth a
388-bp cDNA fragment (GenBankTM accession number
W83893) encoding a partial open reading frame that exhibits a
weak but significant homology to C-terminal regions of UBR1
and UBR2. By employing cDNA library screening and 5-rapid
amplification of cDNA ends PCR, we cloned the 8-kb full-
length mouse cDNA, yielding nine overlapping cDNA frag-
ments that represented two isoforms of a 213-kDa protein
named UBR3. The predicted mouse UBR3 cDNA isoforms,
encoding the proteins of 1,889 and 1,893 residues, respectively,
contained distinct exon/intron boundaries, indicating alterna-
tive RNA splicing (data not shown). Reverse transcription-PCR
analysis detected comparable mRNA levels of UBR3 isoforms
in the liver and skeletal muscle (data not shown). Northern
hybridization indicated that the two UBR3mRNAs, of8 and
6.5 kb, were expressed in a broad range of tissues, with higher
levels in the brain and skeletalmuscle (Fig. 1D). UBR3 exhibited
a low but significant sequence similarity (22% identity) to the
200-kDa mouse UBR1 and UBR2, which are 47% identical (Fig.
1C). Significantly, UBR3 contained all of the domains (the UBR
box, the WxRNG domain, the RING-H2 finger, and the auto-
inhibitory domain) that have been identified in UBR1 and
UBR2 (Fig. 1C). Thus, operationally, UBR1, UBR2, and UBR3
comprise a distinct RING-UBR subfamily of UBR Ub ligases.
UBR3 Binds to E2Ub-conjugating Enzymes HR6A andHR6B—
Wehave previously shown that either of the E2Ub-conjugating
enzymesHR6A andHR6B supports theUBR1-mediated degra-
dation of N-end rule substrates (34) and that mouse UBR1 and
UBR2 bind to HR6B (16). Mouse HR6A and HR6B are 95%
identical and are functional counterparts of the S. cerevisiae E2
enzyme RAD6/UBC2 whose multiple functions include the
N-end rule pathway, where RAD6 is a part of the UBR1-RAD6
Ub ligase (44, 45). To determine whether mouse UBR3 binds to
HR6A andHR6B, we expressed the N-terminally FLAG-tagged
mouse fUBR3 and fUBR1 in S. cerevisiae. Purified GST-HR6A
or GST-HR6B fusion proteins were bound to glutathione-con-
jugated beads, and GST pull-down assays were carried out with
yeast extracts expressing fUBR1 or fUBR3. Both fUBR3 and
fUBR1 bound to GST-HR6A and GST-HR6B but not to S. cer-
evisiae-derived GST-RAD6 (negative control) (Fig. 2, A and B).
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Together with earlier findings with
mouse UBR1 and UBR2 (16, 34),
these results (Fig. 2, A and B) sug-
gest that HR6A and HR6B are E2s
that form the holoenzyme Ub
ligases with, in particular, E3s of the
RING-UBR subfamily. The latter
consists, at present, of UBR1, UBR2,
and UBR3.
UBR3 Does Not Bind to Known
N-end Rule Substrates of UBR1 and
UBR2—The X-peptide pull-down
assay that we developed previously
(17) was used to determine whether
UBR3 can recognize destabilizing
N-terminal residues that are known
to be bound by UBR1 and UBR2
(Fig. 2C). An S. cerevisiae extract
expressing fUBR1, fUBR2, or fUBR3
was incubated with an immobilized
12-mer X-peptide (X-Ile-Phe-Ser-
Thr-Asp-Thr-Gly-Pro-Gly-Gly-Cys,
where X represents Arg (type-1 pri-
mary destabilizing residue), Phe
(type-2 primary destabilizing resi-
due), Asp (secondary destabilizing
residue), Met, Gly, Ser, Thr, or Ala),
followed by a pull-down assay and
anti-FLAG immunoblotting. Con-
sistent with earlier results (17),
fUBR1 and fUBR2 bound to X-pep-
tides bearing either type-1 or type-2
destabilizing N-terminal residues
but not to other N-terminal resi-
dues (Fig. 2D). In contrast, fUBR3
did not bind to any of the tested
X-peptides (Fig. 2D). To verify this
finding, we employed a different
binding assay, with X-SCC1-GST
fusions (where X represents Arg
(type-1 destabilizing residue), Leu
(type-2 destabilizing residue), or
Met (stabilizing residue)). The
SCC1 moiety of these fusions is a
33-kDa separase-produced C-ter-
minal fragment of the S. cerevisiae
cohesin subunit SCC1 that bears
N-terminal Arg and is rapidly
degraded by theN-end rule pathway
(16, 27). As expected, sc-fUBR1
bound to Arg-SCC1 but not toMet-
SCC1. However, fUBR3 did not
interact with any of these substrates
(Fig. 2E), consistent with both the
presentX-peptide data (Fig. 2D) and
the analogous earlier assays with
mouse tissue extracts that identified
UBR1, UBR2, UBR4, and UBR5 but
FIGURE 1. The N-end rule pathway and the UBR3 ubiquitin ligase. A, the mammalian N-end rule pathway.
N-terminal residues are indicatedby single-letter abbreviations for amino acids. The yellowovalsdenote the rest
of a protein substrate. C*, oxidized N-terminal Cys, either Cys-sulfinic acid (CysO2(H)) or Cys-sulfonic acid
(CysO3(H)), produced in reactionsmediated by nitric oxide (NO) and oxygen (O2) or its derivatives, with subse-
quent arginylation of oxidized Cys by the ATE1-encoded isoforms of Arg-tRNA-protein transferase (see Intro-
duction). Through their other substrate-binding sites, these E3 enzymes also recognize internal (non-N-termi-
nal) degrons in other substrates of the N-end rule pathway, denoted by a larger oval. B, locations of the UBR
boxes and several other domains characteristic, inparticular, of E3Ub ligases (17).C, sequencealignmentof the
UBR boxes and autoinhibitory (AI) domains of mouse UBR1–UBR3, and in S. cerevisiae UBR1 and UBR2. The
residue numbers of UBR3 corresponding to its (shown) UBR and AI domains are 120–184 and 1,780–1,862,
respectively. Yellow shading highlights the residues of S. cerevisiae UBR1 that are essential for the UBR1-de-
pendent degradation of type-1 N-end rule substrates (see Ref. 17 and references therein). D, Northern blot
analysis ofUBR3 and-actinusingdifferentmouse adult tissues. Total RNA (20g)was loaded in each lane, and
the ethidium bromide-stained ribosomal RNAs (rRNA) were shown as a loading control (bottom). Data for
-actin and ribosomal RNAs have been presented as controls for Northern blot analysis of UBR4 (17).
FIGURE 2.Analyses of interactions of UBR3with E2Ub-conjugating enzymes andN-terminal residues of
peptide probes. A, m-UBR3 binds to the HR6A E2 enzyme. Extracts (1.5 mg of protein) from S. cerevisiae
expressing FLAG-tagged mouse UBR3 (fUBR3) were incubated with glutathione-Sepharose beads preloaded
with GST-HR6A (mouse HR6A) or GST-RAD6 (yeast RAD6). The bound proteins were eluted, fractionated by
SDS-7.5% PAGE, and immunoblotted (IB) with anti-FLAG antibody. 5% input, 5% of the yeast extract used in a
single GST assay. B, same as in A but with GST-HR6B. C, bead-conjugated X-peptides bearing different N-ter-
minal residues. D, X-peptide pull-down assay with mouse UBR1, UBR2, and UBR3. Extracts from S. cerevisiae
expressing fUBR1, fUBR2, or fUBR3 were incubated with an X-peptide on beads, followed by pelleting of the
beads, washing, SDS-PAGE, and anti-FLAG immunoblotting. E, GST pull-down of S. cerevisiae UBR1 (sc-fUBR1)
and mouse UBR3 with reporter proteins X-SCC1-GST (where X represents Met, Arg, or Leu).
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not UBR3 (17) (data not shown). We conclude that UBR3 does
not bind to known substrates of the N-end rule pathway.
The pattern of E2–E3 interactions in the mammalian RING-
UBR subfamily is analogous to the disposition in S. cerevisiae,
where RAD6, a homolog of HR6A and HR6B, functions as a
common E2 for the yeast RING-UBR subfamily, which consists
of sc-UBR1 (the sole E3 of the S. cerevisiaeN-end rule pathway)
(15) and sc-UBR2,which does not bind toN-end rule substrates
(46). It remains to be determined whether mammalian UBR3 is
functionally analogous to sc-UBR2.
UBR3 Knock-out in Mice Results in Strain-dependent
Phenotypes—To address the physiological functions of UBR3,
we constructedUBR3/mouse strains. BAC clones encoding
mouse UBR3 were isolated from a strain 129-derived SvJ BAC
library. Data base analyses indicated that UBR3 encompasses
130 kb ofmouse chromosome 2 and260 kb of human chro-
mosome 2. Using restriction mapping and sequencing, we
determined the structure of a30-kb genomic fragment span-
ning the 5 upstream region and exons 1–5 of mouse UBR3. In
theUBR3 targeting vector, a region spanning exon 1 (encoding
most the UBR box) and its flanking intron were replaced with
nlsLacZ-neo that encodes E. coli lacZ (-galactosidase) fused to
a nuclear localization signal, followed by the floxed (flanked by
the loxP sites) PGK/Neo cassette. In the resulting UBR3 dele-
tion/disruption allele, the nlsLacZmRNA is produced from the
endogenous UBR3 promoter (Fig. 3A). Mouse chimeras carry-
ing the desired UBR3 (UBR3nlsLacZ) allele were produced
using standard ES cell-based methods (16, 22, 24, 34). These
mice were crossed with either C57BL/6J (denoted as B6) or
129SvImJ (denoted as 129S) wild-type females, yielding F1
UBR3/ offspring in either mixed (B6/129S) or inbred (129S)
backgrounds. The deletion/disruption UBR3 allele was con-
firmed by Southern analysis (Fig. 3B), and the absence ofUBR3
mRNA in UBR3/ mice was confirmed by Northern analysis
(Fig. 3C). The purified GST-UBR3-(182–598) fusion protein
was used as an antigen to produce a polyclonal, affinity-purified
anti-UBR3 antibody (see “Experimental Procedures”). Anti-
UBR3 immunoprecipitation-immunoblotting with mouse tis-
sue extracts confirmed the absence of UBR3 in UBR3/mice
(Fig. 3D).
UBR3/ mice in the mixed (B6/129S) background were
born at a frequency slightly lower than the expectedMendelian
frequency (Table 1). They were fertile and apparently normal,
indicating that UBR3 is not essential for viability and fertility in
this genetic background. In contrast, no UBR3/ mice in the
inbred (129S) background were retrieved from 207 adult mice
and 78 embryos (from E3.5 to E16.5) that were produced from
heterozygous intercrosses, suggesting that UBR3 knock-out in
this background causes lethality in early embryogenesis. We
therefore wished to analyze the phenotypes of UBR3/ mice
in a C57BL/6J (B6)-enriched genetic background. B6-enriched
UBR3/ mice were produced through backcrosses to wild-
type B6 females for 8–12 generations (N8–N12) over a period
of3 years. Unexpectedly, these (B6-enriched)UBR3/mice
exhibited neonatal lethality.
Impaired Suckling and Neonatal Death of B6 Background
UBR3/ Mice—B6 background-enriched UBR3/ embryos
were apparently normal in growth and other developmental
features. At birth, their body weight (1.30 0.04 g; n 15) was
10% lower compared with/ pups (1.46 g 0.05; n 10).
Despite the growth retardation, UBR3/ neonates appeared
normal in body color, breathing behavior, touch response,
FIGURE 3. Construction of UBR3/mouse strains. A, a map of the24-kb
5-proximal region of the130-kb UBR3 gene, the targeting vector, and the
deletion/disruption UBR3/ allele. Exons are denoted by vertical rectangles.
Thick and thin lines describe, respectively, the mouse and bacterial (plasmid-
derived) DNA sequences. Selection markers (thymidine kinase (TK) and neo-
mycin (Neo) genes), the nls-lacZ cassette, and the loxP sites are shown as open
arrows, a solid box, and solid arrowheads, respectively. Southern blot probes
are indicated by solid horizontal bars. Restriction siteswere as follows: ScaI (S),
NheI (N), XbaI (X); and KpnI (K). B, Southern analysis of ScaI-cut andNheI/XbaI-
cutmouse tail DNAs from/,UBR3/, andUBR3/mice, hybridizedwith
0.2-kb (5-probe) and0.6-kb (3-probe) fragmentsofUBR3.C, Northernanalysis
ofm-UBR3 expression, using total RNA from thebrains andhearts of/ and
UBR3/mice. Ethidium bromide-stained ribosomal RNAs, a loading control,
are also shown. D, immunoprecipitation-immunoblotting detection of UBR3
in extracts from the brain, liver, and skeletal muscle (Sk. muscle) of/ and
UBR3/mice. The Control lane denotes a sample of extract from S. cerevisiae
expressing fUBR3. *, bands of IgG.
TABLE 1
Genotypes of 3-week-old offspring from UBR3/ intercrosses in
different genetic backgrounds
Genotype Number of mice of background129S/B6 (mixed) B6 (enriched) 129S (coisogenic)
/ 106 42 54
/ 178 70 153
/ 70 15a 0
Total 354 127 207
Average litter size 8 7.9 5.9
aNumbers in boldface type refer to apparently underrepresented genotypes, in
comparison with/.
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righting, and vocalization, indicating that they were not
severely impaired in cardiovascular and respiratory systems,
motor coordination, and related functions. Notably, however,
60% of UBR3/ neonatal pups exhibited impaired milk
suckling, as determined by the presence and amounts ofmilk in
the stomachs (Fig. 4). AlthoughUBR3/ pups were present in
the nest together with littermates and moved their mouths
apparently normally, the affectedUBR3/ pups becameweak,
exhibited dehydration, and usually died within 2 days after
birth. Dead UBR3/ pups did not exhibit significant anatom-
ical abnormalities in the palate, mouth, and esophagus in com-
parison with wild-type pups or surviving UBR3/ pups. Both
UBR3/ and UBR3/ mothers appeared to nurture their
pups normally, showing standard crouching, retrieving, and
stimulating responses toward all newborns. In summary, the
absence of UBR3, in a B6-enriched background, results in neo-
natal lethality associated with suckling defects, a phenotype we
began to investigate through experiments described below.
Olfaction is crucial for suckling in neonatalmice in that pher-
omones and other olfactants from the nipple are the main sen-
sory cues used in the nipple’s localization by pups. Tactile sen-
sation is also important for suckling behavior, because a rooting
reflex is activated, in part, by touching a nipple, a step that
initiates the rhythmic mouth movement and swallowing.
Indeed, impaired suckling behavior is a typical abnormal phe-
notype in neonates with mutations in genes required for olfac-
tion or tactile sensation (47–50). Mutant neonates impaired in
olfaction or tactile sensation can be partially rescued if the litter
size is reduced (48). To examine this possibility with UBR3/
mice, most of the apparently normal (with milk in their stom-
achs) pups at P1 were removed from three litters (n 29 pups),
so that the litters (each of them reduced to three or four pups)
contained 1–4 suckling-impaired pups per litter. Of the seven
suckling-impaired pups in three reduced size litters, four pups
(three UBR3/ and one UBR3/) survived until adulthood,
whereas oneUBR3/ pup was found dead, and two were can-
nibalized. The surviving UBR3/ pups grew to adulthood
without significant growth retardation and were fertile, with
normal mating behavior. These results suggest that litter size
reduction, and thereby a reduced competition for lactating nip-
ples, could partially rescue neonatalUBR3/ pups and that B6
background UBR3/ neonates die of starvation rather than
developmental failure.
Expression of LacZ/UBR3 in Sensory Cells for Olfactory and
Tactile Sensation—Given the phenotype of impaired suckling
in B6-enriched UBR3/ pups, we employed the nls-lacZ
reporter to examine the expression patterns ofUBR3 (Fig. 3A),
with an emphasis on sensory tissues. LacZ expression patterns
in various organs did not differ significantly betweenUBR3/
and UBR3/ mice, indicating that UBR3 knock-out did not
cause major developmental abnormalities. Odorants and pher-
omones (i.e. the odorants of conspecific origin) are detected
primarily by the main olfactory epithelium (MOE) and the
vomeronasal organ (VNO), respectively (51, 52). The binding of
olfactants to G protein-coupled olfactory receptors (53) on the
surfaces of olfactory sensory neurons inMOE initiates signaling
cascades that involve specific receptor-coupled G proteins and
their transient activation by receptor-bound odorants. This
activation transduces and amplifies the initial signal through
production of cyclic AMP and phosphoinositide derivatives,
activating specific ion channels in an olfactory neuron. The
resulting changes in membrane potential give rise to action
potentials that propagate from olfactory neurons to a glomer-
ular region of the olfactory bulb (OB), where synaptic connec-
tions with mitral cells convey the resulting (processed) signals
to olfactory cortex (OC) (52, 54). In contrast, pheromones are
detected by specific GPCRs in VNO. The axons of vomeronasal
sensory neurons project tomitral cells in glomeruli of the acces-
sory olfactory bulb, relaying the (processed) signals to other
regions of the brain (54). LacZ-marked UBR3 was found to be
prominently expressed in cells of the olfactory pathway, includ-
ing the olfactory cell layer of MOE, a mitral neuron cell layer of
OB, and a pyramidal cell layer of the piriform cortex of OC (Fig.
5, A–E). The expression of UBR3 was also strong in the vome-
ronasal sensory epithelium of VNO and the mitral cells of the
accessory olfactory bulb (Fig. 5, F and G). In neonates, tactile
stimuli to whiskers and sinus hairs of lips activate primary
somatosensory afferent neurons (trigeminal nerve) that inner-
vate vibrissal follicle-sinus complexes (49). UBR3 was promi-
nently expressed in tactile tissues, including the dorsal root
ganglion, trigeminal ganglion, and follicle-sinus complexes
(Fig. 6, A–F). In follicle-sinus complexes, the UBR3-specific
LacZ staining was prominent in cells between hair follicle and
sinus and also in the region of the rete ridge collar (Fig. 6, E and
F). These results indicated thatUBR3 is prominently expressed
in sensory cells involved in olfactory and tactile sensations, both
of which are important for normal suckling in neonatal mice.
FIGURE 4. Impaired suckling inUBR3/neonatal pups.A, appearance of a
single litter of neonatal pups fromacrossbetweenUBR3/parents, showing
the absence (or low amount) of milk in the stomach of a UBR3/ pup. The
relative amounts ofmilk in the stomachswere scored visually as “zero or low”
(I), “intermediate” (II), and “normal” (III). B, percentages of UBR3/, UBR3/,
and / neonatal pups that scored as described above, with 100% repre-
senting all pups of a given genotype. The numbers of scored pupswith these
genotypes are indicatedaswell (n). These comparisons involved, inparticular,
24 UBR3/ pups.
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Expression of LacZ/UBR3 in Sensory Cells for Taste, Hearing,
and Vision—Chemosensation includes smell and taste. Taste
receptor cells respond to gustatory stimuli through GPCRs and
ion channels (55, 56). When stimulated, these cells produce
action potentials that relay gustatory signals to relevant regions
of the brain. Since gustatory sensation provides information
about the quantity and quality of food, including whether it
should be swallowed, the sensing of taste may affect suckling
behavior. UBR3 was found to be
prominently expressed in taste buds
of the fungiform, circumvallate, and
foliate papillae, where 50–100
taste sensory cells are organized
into anatomically distinct groups
(Fig. 6, K and L). Auditory informa-
tion (the intensity and frequencies
of sound) is received and relayed by
mechanosensory hair cells in the
organ of Corti of the inner ear. Volt-
age-gated channels in the stereocilia
of hair cells open and close in
response to physical movements of
hairs (specialized cilia), giving rise
to action potentials (57). Hair cells
form synapses with cells of the
innervated spiral (cochlear) gan-
glion, thereby relaying their signals
to specific regions of the brain.
UBR3 was prominently expressed,
in spatially confined patterns, in the
spiral ganglion and the organ of
Corti of the cochlea in the inner ear
(Fig. 6, G–I). In the organ of Corti,
UBR3 was expressed in the inner
hair cells and outer hair cells, both
of which are mechanosensory cells.
UBR3-specific LacZ staining was
also present in the sensory epithe-
lium of macula and vestibular gan-
glion of the balancing system (Fig. 6,
G and J). Photons of light are
detected by photoreceptor cells in
the retina and are transduced into
action potentials by light-activated
cells. These signals, transmitted and
processed by bipolar neurons and
the rest of the retinal neural net-
work, are conveyed via the optic
nerve to specific regions of the brain
(58, 59). Similarly to the findings
with other sensory organs (Figs. 5
and 6,A–L), the expression of LacZ/
UBR3 was conspicuous in the gan-
glion cell layer and developing pho-
toreceptor cells of the retina (Fig. 6,
M and N). In summary, the UBR-
specific LacZ marker was specifi-
cally and prominently expressed in
sensory cells that underlie the major five senses (smell, touch,
vision, hearing, and taste), suggesting that UBR3-dependent
ubiquitylation regulates the reception or processing of sensory
signals (Figs. 5 and 6).
Because UBR3 is also expressed outside the nervous system
(Fig. 1D), its remarkably specific expression patterns in sensory
tissues (Figs. 5 and 6) reflect only a subset of UBR3 functions,
most of which remain to be discovered. In this initial study of
FIGURE5.ExpressionofmouseUBR3 in thenoseandolfaction-relevantbrain regions.A–G, staining for the
LacZ (gal)-marked UBR3 allele (UBR3nlsLacZ) of 1-day-old (P1) UBR3/ pups. A and B, whole mount LacZ
staining of the nasal cavity and brain, showing the expression of UBR3 in the MOE, VNO, and piriform cortex
(pir). C–F, coronal sections of the nose, withUBR3 expression specifically in olfactory cells (oc) of MOE (C), in the
mitral cell layer (mcl) in periglomerular cells (arrowhead) of OB (D), in the pir region of the olfactory cortex (OC)
(E), and in vomeronasal neurons (arrow) of VNO (F).G, coronal section of the brain, withUBR3 expression in the
accessory olfactory bulb (AOB) (dotted area). sc, support cells; bc, basal cells; lot, lateral olfactory tract. H–K,
immunohistochemical detection of the olfactory marker protein (OMP) (H and I) and type III adenylyl cyclase
(AC3) (J and K) in UBR3/ (H and J) and UBR3/ (I and K) P1 pups. The target-specific staining was significant
in cilia (arrows), olfactory cells (arrowheads), and axon bundles (asterisks).
FIGURE 6. Expression of mouse UBR3 in tissues relevant to the sensation of touch, hearing, taste, and
vision. A–F, expression ofUBR3, as determined by LacZ staining (see the legend to Fig. 5), in tissuesmediating
the sensation of touch, such as the dorsal root ganglion (drg) of an E13 UBR3/ embryo (A), the trigeminal
ganglion (TG) of a P2UBR3/ pup (B and C), as well as the upper part (solid arrowheads) and superficial end of
vibrissal follicle-sinus complexes of a P1 UBR3/ pup (D–F). nt, neural tube; nc, nasal cavity; tn, tongue; sn,
sinus; hs, hair shaft; hf, hair follicle; m, matrix. G–J, expression of UBR3 in auditory and balancing organs,
particularly in the spiral ganglion (SG) and the OC of the cochlea in the inner ear (G–I). Inner hair cells (IHC) and
outer hair cells (OHC) in the organ of Corti that express UBR3 (I) are mechanosensory cells. UBR3 is also
expressed in the sensory epitheliumofmacula (J) and the vestibular ganglion (VG) (G) of the balancing system.
GG, geniculate ganglion. K and L, expression of UBR3 in the organs of taste, especially in taste buds of three
papillae (fungiform (fgp), foliate (flp), and circumvallate papillae (cvp)). Note high UBR3 expression in the
sensory epithelium of taste buds (dashed lines) (L).M and N, expression of UBR3 in specific tissues of the eye in
a P2 UBR3/ pup, especially in the lens (Ln), in the ganglion cell layer (gcl) of retina, and in the outer region of
developing retina (arrowhead).
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UBR3, which includes its cloning, biochemical characteriza-
tion, and the construction ofUBR3/mice, we focused on the
expression of UBR3 in sensory organs primarily because of the
serendipitous discovery of suckling impairment in UBR3/
neonates (Fig. 4), a defect that is likely to stem, at least in part,
from abnormal olfaction.
UBR3/ Mice Are Impaired in Olfaction-based Behavior—
Histological examination of sections of B6-enriched UBR3/
heads at E18 or P1 did not detect anatomical abnormalities in
OE, OB, and piriform cortex, where UBR3 is prominently
expressed (see above). Immunohistochemical staining of sec-
tions from/ and UBR3/ P2 pups also did not reveal sig-
nificant alteration in the expression and distribution of olfac-
tory neuronal markers, such as the olfactory marker protein
(OMP) and type III adenylyl cyclase (Fig. 5,H–K). To determine
the survival and growth of neurons, we measured the levels of
neurotrophins inUBR3/ animals at E18 andP1 togetherwith
littermate controls.UBR3 knock-out did not affect significantly
the levels of nerve growth factor (0.16 0.02 pg/mg of tissue in
/ (n 6), 0.19 0.02 in/ (n 10), and 0.15 0.02 in
/ (n 7)) and brain-derived neurotrophic factor (10.1 1.3
pg/mg in/ (n 6), 10.5 1.3 in/ (n 10), and 10.5
0.8 in / (n  7)) in the brains of P1 pups, as were E18
embryos (data not shown). Microarray analyses of 22,000
mouse genes (Affymetrix GeneChips) coupled with selective
quantitative reverse transcription-PCR with mRNAs isolated
from/ and UBR3/ P1 brains did not detect genes whose
expression was altered more than 2-fold in the mutant.3
The ability of olfactory neurons to convey signals to OB is
underlain by the biosynthesis, transport, and release of specific
neurotransmitters, such as catecholamines (60). We deter-
mined the effect ofUBR3 loss on the levels of neurotransmitters
and related substances, including dopamine, noradrenaline,
homovanillic acid (a major catabolite of dopamine), -ami-
nobutyric acid, glutamate, serotonin, 5-hydroxyindoleacetic
acid, taurine, and tyrosine. In the whole brains at E18 or P1, the
absence of UBR3 did not affect the levels of these compounds.
In contrast, the OB of P1 UBR3/ neonates contained a sig-
nificantly reduced level of noradrenaline but not of other tested
compounds, compared with control neonates. Dopamine, a
precursor of noradrenaline, was also affected in P1 UBR3/
pups to a lesser extent (Table 2). Since earlier studies implicated
catecholamines in olfaction and other senses (61–63), the
above results (Table 2) suggest that UBR3 is required, in partic-
ular, for normal regulation of catecholamines.
The lethality associated with impaired suckling in UBR3/
neonates (Fig. 4) and the expression ofUBR3 in sensory cells of
the olfactory pathway (Fig. 5) suggest that one physiological
function of UBR3 is in olfaction. To begin addressing this pos-
sibility, we employed an odor-based behavioral test, with 7–17-
week-old UBR3/ mice that naturally survived or were res-
cued by litter size reduction. In a pretest, mice were exposed
three times (2-min exposures with 1-min intervals) to a water-
dipped cotton swab, and the number of times amouse sniffed or
approached to explore the swab was recorded at each trial. The
control (/ and UBR3/) and the UBR3/ mice (both
males and females) proactively sniffed or explored water-
dipped swabs in pretests in which swab was a novel object (Fig.
7A). The sniffing counts of all three genotypes decreased in
subsequent trials in which a water-dipped swabwas no longer a
novel object (Fig. 7A). These results suggest thatUBR3/mice
are not significantly impaired in the exploratory activity and are
normally habituated to the swab. One minute after the pretest,
the same procedure was repeated but with a swab laced with an
odorant, such as isoamyl acetate (a pearlike odor), citral (a lem-
on-like odor), ethyl vanillin (a vanilla-like odor), and geraniol (a
rose-like odor). As expected, the control (/ and UBR3/)
mice actively responded to the swab lacedwith these odors (Fig.
7B). In contrast, UBR3/ mice were found to exhibit the
behavioral anosmia toward tested odors. Remarkably, this
defect was confined toUBR3/ females (Fig. 7B). Thus, UBR3
appears to regulate olfactory behavior and does so, in adult
mice, in a gender-specific manner. Together with the expres-
sion patterns of UBR3 (Figs. 1D, 5, and 6), these initial func-
tional insights, the beginning of broader explorations, hint at
wide ranging functions of UBR3, both inside and outside the
nervous system.3 T. Tasaki and Y. T. Kwon, unpublished data.
TABLE 2
Measurements of neurotransmitters and related compounds in UBR3/mice






pg/mg tissue pg/mg tissue pg/mg tissue pmol/mg tissue pmol/mg tissue pg/mg tissue pg/mg tissue pmol/mg tissue pmol/mg tissue
E18 braina
/ 95.2 9.7 46.4 7.6 33.1 6.0 1.57 0.06 5.08 0.12 53.9 7.0 217 25 21.6 0.4 3.98 0.29
/ 85.1 4.2 40.5 4.4 26.7 2.3 1.61 0.04 5.05 0.13 52.7 6.6 209 6 21.1 0.5 3.18 0.19
/ 89.0 6.7 43.1 4.9 30.4 2.9 1.58 0.06 5.14 0.23 61.7 6.8 183 10 21.7 0.7 3.68 0.20
P1 brainb
/ 164 9 99.0 3.5 47.3 6.0 1.46 0.09 3.46 0.13 203 33 944 95 27.9 0.9 3.62 0.52
/ 185 11 108 4.3 41.0 6.4 1.56 0.10 3.77 0.28 245 33 947 89 29.8 1.6 3.68 0.33
/ 162 3 93.1 2.9 36.3 4.7 1.31 0.04 3.22 0.12 223 46 1114 99 26.7 0.7 3.10 0.26
P1 OBb
/ 100 16.9 54.9 11.4 55.9 12.3 1.23 0.24 5.14 0.50 61.0 7.2 267 30 38.3 2.4 3.55 0.45
/ 80.5 19.4 56.8 5.9 51.8 6.2 1.17 0.10 4.43 0.37 66.9 4.0 286 25 31.9 2.5 3.25 0.41
/ 41.4 14.3c 32.4 8.6 50.2 12.3 1.00 0.11 3.78 0.38 61.3 9.0 321 40 30.4 2.7 2.62 0.46
a/ (n 7),/ (n 10),/ (n 10).
b/ (n 6),/ (n 10),/ (n 7).
c p 0.05 versus P1 OB/; one-way analysis of variance.
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Our previous work (17) identified mammalian E3 Ub ligases,
termed UBR1–UBR7, that contain a distinct domain named the
UBRbox (Fig. 1,B andC). These E3s includeUBR1 andUBR2, the
previously knownUb ligases of the N-end rule pathway. Such E3s
recognize N-end rule substrates through the binding, in part
through their UBR domains, to destabilizingN-terminal residues.
The present study, a part of our ongoing exploration of the UBR
family E3s and the N-end rule pathway, describes the cloning and
extensive characterization of the mouse UBR3 Ub ligase. We
report that UBR3 is a 213-kDa RING finger E3 that also contains
the UBR domain and exhibits a low but statistically significant
similarity to UBR1 and UBR2 outside the above two domains as
well. (The sequenceofUBR3 is 22% identical to thoseofUBR1and
UBR2, which are 47% identical.) These three Ub ligases are, thus
far, the sole members of the RING-UBR subfamily of the above
UBR family of E3s. We found that UBR3 interacts with the Ub-
conjugating (E2) enzymes HR6A or HR6B, which also interact
with theother twoE3sof theRING-UBRsubfamily, theUBR1and
UBR2Ub ligases of theN-end rule pathway.Despite this similarity
and the presence of aUBRbox inUBR3, our findings indicate that
UBR3 does not bind to knownN-end rule substrates of UBR1 and
UBR2.
The fact that only a subset of UBR-box proteins can bind to
destabilizingN-terminal residues (16, 17) (this study), indicates
that the sequencemotif termed theUBRbox (Fig. 1C) functions
as a scaffold for specific three-dimensional structures of dis-
tinct binding specificities. At present, the only known class of
specific ligands that bind to UBR boxes is that of N-degrons,
specifically their destabilizing N-terminal residues, in either
protein size or peptide size ligands. However, given our results
with UBR3 (Fig. 2), other, non-N-end rule physiological ligands
of the UBR domain (e.g. those that bind to UBR of UBR3) are
expected to exist as well. One function of the UBR boxes in the
known N-recognins (Fig. 1) is nutritional sensing. Specifically,
S. cerevisiae UBR1 binds, in part through its UBR box, to short
peptides bearing destabilizing N-terminal residues. This bind-
ing allosterically activates a third substrate-binding site of
UBR1 that targets an internal (non-N-degron) degradation sig-
nal of CUP9, a transcriptional repressor of peptide import. This
design of yeast UBR1 yields a positive feedback circuit that can
detect intracellular peptides and up-regulate their import (16,
26, 33). By analogy, a UBR box of UBR3 may bind to (currently
unknown) small metabolites. Similarly to the binding of dipep-
tides to the type-1/2 binding sites of UBR1 (see Introduction),
the binding of a small effector to UBR3 may activate its other
substrate-binding site (presumed to exist by analogy to UBR1/
UBR2), thereby altering the rate of ubiquitylation of a relevant
regulatoryprotein(s). If so, one interestingpossibility is that a small
compound ligand and/or a protein target(s) of UBR3 may be the
same in otherwise diverse physiological processes that involve
UBR3 in different sensory tissues.
The phenotypes of UBR3/ mouse strains that were char-
acterized in this work are strongly dependent on genetic back-
ground. Specifically, UBR3/mice of the inbred (129S) back-
ground died as early embryos, for reasons that remain to be
determined. In contrast,UBR3/mice of themixed (B6/129S)
background, although they were born at lower than expected
frequencies (Table 1), were fertile, of normal size, and appar-
ently normal otherwise as well. Remarkably, our systematic,
long term (over3 years) enrichment ofUBR3/mice in the
B6 genetic background yielded a reproducible and conspicuous
phenotype, a strongly increased lethality of newbornUBR3/
pups, largely if not entirelybecauseof impaired suckling (Fig. 4 and
Table 1). The dependence of viability and other phenotypes of
UBR3/mice on their genetic background (Table 1) indicate the
presence of genes whose alleles functionally interact withUBR3.
The finding that UBR3 is prominently expressed in neurons
and/or other cells thatmediate sensory pathways, including the
fivemajor senses (Figs. 5 and 6), suggested a role of UBR3 in the
corresponding physiological processes. The vision, smell, and
taste are mediated primarily by specific GPCR signaling path-
ways. For example, the rhodopsin, a photon-stimulated photo-
receptor in the eye’s retina, initiates a cGMP-dependent signal
transduction cascade that leads to the action potential (58). The
MOE, the VNO, and taste buds also express specific GPCRs
that recognize, respectively, various odorants, pheromones,
and a set of substances that elicit sensations of taste, such as
sweet, bitter, and umami (56). The secondmessengers for these
sensory GPCR signaling pathways are primarily cyclic AMP
(olfactory neurons and taste sensory cells (for sweet and
FIGURE 7.Olfaction-dependent behavioral tests of UBR3/mice. A, pre-
testing sessions with/ and UBR3/ (wild-type/heterozygous (W/H)) ver-
sus UBR3/ (KO) mice, using a cotton swab laced with water (see “Odor-
based Behavioral Tests”; 7–17-week-old mice, with littermates as controls).
B, control and UBR3/ mice were subjected to four consecutive odorant
tests 1 min after pretesting, using isoamyl acetate, citral, ethyl vanillin, and
geraniol as odorants. The data are expressed as the S.E. of the sniffing counts
during the first 2-min exposures towater or odorants. *, p 0.01; **, p 0.06;
***, the sniffing count was zero. p refers to probability values inWelch’s t test.
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umami)) and inositol 1,4,5-trisphosphate (vomeronasal sen-
sory neuron and taste sensory cells (for bitter)), in contrast to
cGMP in photoreceptor cells. The taste sensory cells utilize
sodiumandpotassiumchannels to sense, respectively, salty and
sour substances, and the signal transduction cascades involved
do not depend on GPCR activation. In yet another example of
the diversity of signaling pathways in different sensory organs,
the senses of touch and hearing are triggered by mechanical
force-transducing molecules, such as mechanosensitive ion
channels. In sum, the mechanisms underlying signal reception,
receptor activation, and intracellular signal transduction tend
to be distinct in different sensory settings. By contrast, the pro-
cesses of synaptic transmission, downstream of the above sig-
naling cascades, involve largely similar molecular mechanisms.
Thus, one possibility is that UBR3, which is expressed in all of
the above sensory systems (in addition to other cell types as
well), may regulate a common step of “downstream” synaptic
transmission rather than signal initiation or intracellular signal
transduction. Reduced amounts of noradrenaline and dopam-
ine in olfactory bulbs ofUBR3/ pups (Table 2) are consistent
with this possibility.
Because a suckling defect of UBR3/ pups, which could be
partially rescued by a decreased litter size, can be caused by
impaired olfaction, and because UBR3 is expressed in olfactory
tissues (Fig. 5; see “Results”), we carried out tests for behavioral
anosmia in UBR3/ mice. Strikingly, the anosmia in adult
UBR3/ mice, although present and strong, was found to be
confined to UBR3/ females, whereas the increased lethality
ofUBR3/ neonates in the B6-enriched background was gen-
der-neutral (Table 1). This gender-specific difference in olfac-
tory behavior (Table 1 and Fig. 7) can be reconciled if newly
born UBR3/ pups of either gender were anosmic and if
UBR3/ males but not UBR3/ females recovered their
olfaction by the time of sexual maturity, when behavioral tests
for anosmia were carried out. Examination of these and related
possibilities will require electrophysiological tests with nasal
epithelia of wild-type and mutant pups. To the best of our
knowledge, a gender dependence of anosmia has been reported
in regard to the induction of olfactory sensitivity in normal
humans (64) but not in amousemutant (Fig. 7). One possibility
is that a suppressor gene in the male-specific Y chromosome
rescues the anosmia phenotype of adult UBR3/ males. A
putative Y-borne suppressor may or may not be a Ub ligase.
Since UBR3 is also expressed outside the nervous system
(Fig. 1D), its remarkably specific expression patterns in sensory
tissues (Figs. 5 and 6) reflect only a subset of UBR3 functions,
most of which remain to be discovered. Our initial functional
results (Fig. 7), the beginning of broader explorations, hint at
wide-ranging roles of UBR3, both inside and outside the nerv-
ous system.
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